Quantitative determination of drugs & pharmaceuticals using p-chloranilic acid as reagent

International Journal of ChemTech Research

Volumn 4, Issue 1, 2012, Pages 79-91

  Fathima, Arshiya ^a   Rao, Sayaji ^a   Venkateshwarlu, G ^a  

^a OSMANIA UNIVERSITY   (India)

Author keywords

Drugs; P chloraniliac acid; Quantification; Spectrophotometry; Validation

Indexed keywords

ACETONITRILE; AUTIDINE; CHLORANIL; CYTOTAM; DEXTROMETHORPHAN; DYTOR; FAMOTIDINE; KETOROLAC TROMETAMOL; PANTOPRAZOLE; PERMANGANATE POTASSIUM; Q PIN; QUETIAPINE; SALMETEROL XINAFOATE; SUMATRIPTAN SUCCINATE; TAMOXIFEN CITRATE; TORASEMIDE; UNCLASSIFIED DRUG;

ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; DRUG ACTIVITY; DRUG CAPSULE; DRUG DETERMINATION; DRUG INDUSTRY; DRUG MECHANISM; DRUG STABILITY; DRUG STRUCTURE; DUODENUM ULCER; GASTROESOPHAGEAL REFLUX; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPERTENSION; LIMIT OF DETECTION; LIMIT OF QUANTITATION; MIGRAINE; PAIN; PEPTIC ULCER; PSYCHOSIS; REACTION TIME; REFLUX ESOPHAGITIS; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; STOICHIOMETRY; STOMACH ULCER; TABLET;

EID: 84856888217     PISSN: None     EISSN: 09744290     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Adikwu M.U., Ofokansi K.C and Attama A.A., Spectrophotometric and thermodynamic studies of the charge - transfer interaction between diethylcarbamazine citrate and chloranilic acid. Chem Pharm Bull 1999, 47, 463-466.
2. Basavaiah K and Charan V. S., The Use of Chloranilic Acid for the Spectrophotometric Determination of Three Antihistamines Turk J. Chem. 2002, 26,653-661.
3. Raghu M and Basavaiah K, Two charge-transfer complexation reactions for spectrophotometric determination of pheniramine maleate using pacceptors J Sci. Ind. Res. 2011,70, 851-858.
4. Adegoke O.A., Babalola C.P, Isaac P.O.K. and Kotila O.A., Spectrophotometric studies of the charge-transfer complexation between Lumefantrine and Chloranilic acid in acetonitrile. Acta Pharm. Sci., 2011,53, 135-149.
5. R Foster "Organic Charge Transfer Complexes", Academic Press, London and New York, 1969, 304.
6. Humphries T. J. and Merritt G.J., Review article: drug interactions with agents used to treat acidrelated diseases. Aliment. Pharmacol. Ther. 1999, 13, 18-26.
7. Mohite M.T., Shet S.N., Shaikh S., Vaidya V.R. and Karodi R.S., Analytical method development of Famotidine USP in bulk and single component formulation Inter J Res Ayurveda & Pharm, 2010,1, 475-479.
8. Buckley M.M., Brogden R.N. Ketorolec: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potentials. Drugs. 1990, 39, 86-109.
9. Jitendra D. F., Harshal P. M., Rajesh Y. C. and Vijay R.P., Simultanious Spectrophotometric Estimation of Ofloxacin and Ketorolac Tromethamine in Ophthalmic Dosage Form Inter. J. Chem.Tech. Res.,2009,1, 189-194.
10. Schwartz A.R., Pizon A.F., Brooks D.E.,Dextro-methorphan-induced. Clinical Toxicology (Philadelphia, Pa.) 2008, 46, 771-3.
11. Gouda A.A.F., Sheikh R., Shafey Z. Hossny N. and Azzazy R.,Spectrophotometric Determination of Pipazethate HCl and Dextromethorphan HBr using Potassium Permanganate Int. J Biomed Sci, 2008,4, 294-302
12. Keck Jr P. E., McElroy S. L. and Strakowski S. M. Schizoaffective disorder: role of atypical antipsychotics, Schizophrenia Res.1999, 35 S5-S12.
13. Rajendraprasad N, Basavaiah K, Vinay K B, Sensitive and selective extraction-free spectrophotometric determination of quetiapine fumarate in pharmaceuticals using two sulphonthalein dyes, J. Pre-Clin. and Clin. Res., 2010, 4, 024-031.
14. Goodman and Gillman's, The Pharmacological Basis of Therapeutics, 2001, 10th Edition, 736-740.
15. Kondawar M S, Shah R R, Waghmare J J, Malusare M K and Shah N D, UV Spectrophotometric Method for Simultaneous estimation of Salmeterol xinafoate and Fluticasone propionate in Bulk and Dosage form.Int.J. PharmTech Res.2011,3, 1801-1806
16. Razzaque Z, Heald M.A., Pickard J.D.,. Vasoconstriction in human isolated middle meningeal arteries determining the contribution of 5-HT1B-and 5-HT1F-receptor activation. Br J Clin Pharmacol.1998, 47, 75-82.
17. Kalyana Ramu B and Raghubabu K., Visible spectrophotometric determination of sumatriptan succinate in tablet dosage forms using folin reagent Int J Pharm Biomed Sci., 2010,3, 49-52.
18. Jordan V.C., A current view of tamoxifen for the treatment and prevention of breast cancer. Br J Pharmacol, 1993,110, 507-17.
19. Santana D.P., Braga R.M.C., Strattmman R., Albuquerque M.M., Bedor D.C.G.and Leal L.B Reversed phase HPLC determination of tamoxifen in dog plasma and its pharmaco-kinetics after a single oral dose administration Quim. Nova, 2008,31, 47.
20. Dunn C.J., Fitton A, Brogden R.N. Torasemide. An update of its pharmacological properties and therapeutic efficacy. Drugs, 1995, 49, 121-42.
21. Bagade S.B. and Patil S K, Spectrophotometric Estimation of Torsemide in Tablet Dosage FormUsing Chemical Derivatization Technique. Inter. J Pharm. Qual. Assur., 2 (2010) 52-55
22. The Martindale The complete drug reference (2006) 35thEd. published pharmaceutical press, lambeta high street, Londan SEI 75M, UK.
23. O Zenita Devi, K Basavaiahand, K. B. Vinay., Sensitive and selective spectrophotometric determination of Pantoprazole sodium in pharmaceuticals using permanganate Chem. Ind & Chem. Eng Quart. 2010, 16, 97-102.
24. International Conference on Hormonization (ICH) of Technical Requirement for the Registration of Pharmaceuticals for Human use, Validation of analytical precedures: definations and Terminology Genera. 1996.
25. Benesi H.A. and Hildebrand J.H.,A Spectrophotometric Investigation of the Interaction of Iodine with Aromatic Hydrocarbons, J, Am. Chem Soc, 1949,71, 2703-2707.